Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients

New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients

July 17, 2008

Study identifies possible markers for cancer prognosis

PROVIDENCE, R.I. - Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.




According to the study, published in the July 1 issue of Clinical Cancer Research, patients who had poor outcomes following surgery for stomach cancer also had extremely low amounts of two proteins, known as gastrokine 1 and 2 (GKN1 and GKN2), which are produced by normal stomach cells.

The study's findings confirm previous research showing that once stomach cells become cancerous, they manufacture very low amounts of GKN1 and GKN2. However, this is the first known study to link these low protein levels with outcomes following stomach cancer surgery. Researchers say this discovery could eventually help physicians better determine and individualize therapy for stomach cancer, including which patients should be offered chemotherapy and other treatments in addition to surgery.

"Unfortunately, stomach cancer is difficult to cure unless it's discovered early, but because the early stage of the disease has very few symptoms, the cancer is usually advanced by the time it's diagnosed," says lead author Steven Moss, MD, a gastroenterologist with Rhode Island Hospital and an associate professor of medicine at The Warren Alpert Medical School of Brown University.

"That's what makes our findings so significant, because if the potential markers identified in our study can help predict a patient's prognosis, we can decide right away which course of action to take and hopefully help patients live longer and more comfortably," he adds.

According to the National Cancer Institute, approximately 760,000 cases of stomach cancer are diagnosed worldwide each year. Microscopically, stomach cancers can be subdivided into those which appear "diffuse" (a more aggressive form of cancer that can occur throughout the stomach and is more likely to spread) or "intestinal" (resembling the cells normally found only in the small or large intestines). Stomach cancers of both types are often triggered by a chronic infection brought on by Helicobacter pylori (H. pylori), a common bacterium that causes stomach inflammation and ulcers. Surgery is the most common treatment for stomach cancer and can include partial or full removal of the stomach. The five-year relative survival rate of patients with stomach cancer is 24 percent.

Moss, an expert on H.pylori, and colleagues initially set out to learn more about what the bacterium does to normal stomach cells. They focused on GKN1 and GKN2 because these proteins are also suppressed by stomach infections caused by H. pylori.

After looking at tissue samples from more than 150 stomach cancer patients who underwent surgery, the researchers discovered a near total suppression of GKN1 and GKN2 in the majority of patients. This was particularly evident in those patients with the diffuse variant of stomach cancer. More than three-quarters of these patients had extremely low levels of GKN1 and 85 percent had nearly nonexistent levels of GKN2.

Furthermore, in those patients with the intestinal variant of stomach cancer, very low levels of GKN 1 or GKN 2 at the time of surgery were associated with a significantly worse outcome. The median survival was about two years in these patients compared to a survival of more than 10 years for patients with normal levels of GKN1 or GKN2.

Researchers do not yet know the exact function of GKN1 and GKN2. They say further studies are needed to demonstrate the mechanisms responsible for the loss of GKN1 and GKN2 in this patient popoulation as well as the clinical biomarker potential of these two proteins.

The study included tissue samples from 155 patients with stomach cancer (81 men and 74 women) who underwent surgery at Rhode Island Hospital and The Miriam Hospital, both in Providence, R.I. The average age at surgery was 72 years. All four stages of cancer were represented in the study, including 37 patients with Stage I, 44 patients with Stage II, 34 patients with Stage III, and 40 patients with Stage IV. More than 61 patients were being treated for the intestinal variant of stomach cancer while 90 patients had the diffuse variant.

Lifespan



Related Stomach Cancer Current Events and Stomach Cancer News Articles Stomach Cancer Current Events and Stomach Cancer News RSS Stomach Cancer Current Events and Stomach Cancer News RSS
Researchers describe how chronic inflammation can lead to stomach cancer
A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer - the second leading cause of cancer-related mortality in the world.

H. Pylori bacteria may help prevent some esophageal cancers
Some bacteria may help protect against the development of a type of esophageal cancer, known as adenocarcinoma, according to a new review of the medical literature. These bacteria, which are called Helicobacter pylori, live in the stomachs of humans.

Going from ulcers to cancer
Researchers have uncovered a big clue as to why some of the bacteria that cause stomach ulcers pose a greater risk for serious problems like stomach cancer than others; it turns out these bacteria can exploit the surrounding stomach cells to protect them from the immune system.

OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

Early treatment of stomach infection may prevent cancer
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer.

Stomach stem cell discovery could bring cancer insights
Scientists have identified and described stem cells specific to several tissues and organs of the body - key master cells that give rise to the specialized cell types characteristic of that organ.

Stomach cancer rate set to fall further 25 percent over next decade
New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut.

Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism.

Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism.

Researcher hits bulls-eye for antibiotic target
A Purdue University researcher has opened the door for possible antibiotic treatments for a variety of diseases by determining the structure of a protein that controls the starvation response of E. coli.
More Stomach Cancer Current Events and Stomach Cancer News Articles


Breast Cancer and Iodine : How to Prevent and How to Survive Breast Cancer
by David Derry

    I have taken my personal experience in practice along with the details of treatment of patient together with published literature and proposed a testable theory of breast cancer. The lack of a theory of cancer and especially breast cancer has made treatment difficult and empirical.     The book is divided into four parts. The first part discusses iodine. From published facts, we...



Cancer Of The Stomach, A Clinical Study Of 921 Operatively And Pathologically Demonstrated Cases: With A Chapter On The Surgical Treatment Of Gastric Cancer
by Frank Smithies

This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our...



Stomach Cancer Medical Guide
by Qontro Medical Guides

The Stomach Cancer Medical Guide is a publication which has been designed to better help readers understand Stomach Cancer. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Stomach Cancer. The Stomach Cancer Medical Guide is highly recommended for those interested in understanding and...

CANCER OF THE STOMACH. A Striking Contrast in Clinical Features.
by H. H. (SIGNED) RAYNER

Gale Encyclopedia of Medicine: Stomach cancer
by Bob Kirsch PhD

The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major...

CANCER OF THE STOMACH AS A SURGICAL PROBLEM.
by Reginald T. PAYNE

Stomach cancer: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed.
by Lata, Ph.D. Cherath, Bob Kirsch

Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic...

Garlic and onions vs. stomach cancer. (research in China): An article from: Medical Update

This digital document is an article from Medical Update, published by Benjamin Franklin Literary & Medical Society, Inc. on March 1, 1989. The length of the article is 1851 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web...

Epidemiology of Stomach Cancer: Key Questions and Answers: Proceedings of the Meeting on the Future Inquiries Into the Epidemiology of Stomach
by Takeshi Hirayama

Ulcer-cancer of the stomach (carcinoma ex ulcere ventriculi) (Macewen momorial lecture)
by Matthew J Stewart

© 2009 BrightSurf.com